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Cystic Fibrosis (CF) is an autosomal recessive disorder caused by mutations in the Cystic
Fibrosis Transmembrane Conductance Regulator (CFTR) gene. CF-related diabetes
(CFRD) is one of the most prevalent comorbidities of CF. Altered glucose homeostasis
has been reported in CF patients. The mechanism has not been fully elucidated.
Besides the consequence of pancreatic endocrine dysfunction, we focus on insulin-
responsive tissues and glucose transportation to explain glucose homeostasis alteration
in CFRD. Herein, we found that CFTR knockout mice exhibited insulin resistance and
glucose tolerance. Furthermore, we demonstrated insulin-induced glucose transporter
4 (GLUT4) translocation to the cell membrane was abnormal in the CFTR knockout mice
muscle fibers, suggesting that defective intracellular GLUT4 transportation may be the
cause of impaired insulin responses and glucose homeostasis. We further demonstrated
that PI(4,5)P2 could rescue CFTR related defective intracellular GLUT4 transportation,
and CFTR could regulate PI(4,5)P2 cellular level through PIP5KA, suggesting PI(4,5)P2
is a down-stream signal of CFTR. Our results revealed a new signal mechanism of CFTR
in GLUT4 translocation regulation, which helps explain glucose homeostasis alteration
in CF patients.
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INTRODUCTION
Cystic fibrosis (CF) is one of the most common autosomal recessive disorders in the Caucasian
population. It is caused by mutations in the CFTR gene. CF-related diabetes (CFRD) affects 19%
of adolescents with CF (Moran et al., 2010), 50% adults CF patients (Moran et al., 2009, 2010),
indicating that CFRD is a progressive complication of CF. Despite advances in therapies designed
to address the disease’s symptoms, the death rate is still high. As a result, it is crucial to study the
mechanism of CFRD thoroughly.
One of the prevailing mechanistic beliefs is that CFRD results from defective insulin secretion
of pancreatic β-cell, which is due to the combination of chronic pancreatitis and eventual loss of
the islet cells (Cucinotta et al., 1994; Marshall et al., 2005; Costa et al., 2007; Mohan et al., 2009;
Guo et al., 2014). Autopsy data confirmed the eventual loss of islet tissue and decreased β-cell
Abbreviations: CF, Cystic Fibrosis; CFTR, Cystic Fibrosis Transmembrane Conductance Regulator; CFRD, Cystic Fibrosis
related diabetes; GLUT4, Glucose Transporter 4.
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numbers in aged CF patients (Iannucci et al., 1984; Lohr et al.,
1989). However, most CF patients demonstrate abnormalities
in glycaemic control regardless of the class and severity of the
CFTR mutation (Wooldridge et al., 2015). Of the thousand
CFTR mutations that have been identified, approximately 20 are
understood to be disease-causing and are categorized into five
classes of mutations of increasing disease severity (Manderson
Koivula et al., 2017). CFTR in the regulation of insulin secretion
and β cell function has also been reported as the mechanism of
CFRD by several recent studies (Stalvey et al., 2006; Edlund et al.,
2014; Guo et al., 2014; Fontes et al., 2015), which cannot fully
explain the impaired insulin responses and glucose homeostasis
reported in CF patients. In addition to the traditional view that
CFRD is the consequence of pancreatic endocrine dysfunction,
we speculated that CFRD might also affect insulin-responsive
tissues’ function.
Several studies found that CF patients with overt diabetes
exhibited peripheral and hepatic insulin resistance (Moran et al.,
1994; Holl et al., 1995; Hardin et al., 2001; Fontes et al., 2015;
Boudreau et al., 2016). However, little is known regarding
the mechanism of CFTR loss-of-function in insulin resistance.
Insulin facilitates the entry of glucose into muscle, adipose,
and several other tissues. The typical mechanism by which
cells can take up glucose is by facilitated diffusion through a
family of hexose transporters. Skeletal muscle provides the most
substantial contribution (∼70%) of insulin-dependent glucose
disposal, and this process is mediated by the insulin-responsive
glucose transporter 4(GLUT4) (Bouche et al., 2004; Leto and
Saltiel, 2012). As a result, we speculated that CFTR deficiency
might result in impaired insulin action and GLUT4 dysfunction
in skeletal muscle. In this study, we found that CFTR knockout
mice exhibited altered glucose homeostasis, and the reason was
defective intracellular GLUT4 transportation.
MATERIALS AND METHODS
Cell Culture and Transfection
Flexor Digitorum Brevis (FDB) muscle fibers isolation from
mice skeletal muscle was previously described (Park et al.,
2014). Mouse skeletal muscle cell lines, C2C12 myoblasts, were
cultured in DMEM (GIBCO #11965) supplemented with 10%
FBS (HyClone #30071.03). C2C12 myotubes differentiation was
then induced by switching the medium to DMEM supplemented
with 2% HS (GIBCO #26050070). The medium was changed
every 24 h. The plasmid of myc–GLUT4–EGFP, bearing the
c-Myc epitope tag in the first extracellular loop and GFP at
the carboxyl terminus, was purchased from addgene (#52872).
According to the manufacturer’s instructions, the plasmid was
transfected into HEPG2 and Hela cells using Lipofectamine 2000
(Invitrogen). C2C12 myoblasts and myotubes were transfected
with adenovirus (Vigenebio, China) to express myc–GLUT4–
EGFP protein.
Immunofluorescent Analysis
Cells that express myc–GLUT4–EGFP were cultured with media
supplemented with 1% FBS overnight and then were treated
with insulin (100 nM) for 30 min. Cells were then fixed
with 4% paraformaldehyde, followed by immunocytochemistry
using the anti-Myc antibody (Beijing TDY Biotech LTD,
#TDY002) and Cy3 -conjugated anti-mouse IgG antibody
(Beijing CWBIO, # CW0145S). The cells were imaged with
a spin disk confocal system (Revolution XD; ColdSpring
Science Corporation) with a CSU-X1 confocal head (Yokogawa)
mounted on an inverted microscope (IX81ZDC2; Nikon) with
Perfect Focus, using an EMCCD camera (iXon3 DU-897D-C00-
#BV; Andor). MetaMorph controlled image acquisition and all
other peripherals.
Animal Experiments
All methods were carried out following relevant guidelines
and regulations. All experimental protocols were approved
by the University Ethics Committee, Institute of Molecular
Medicine, Peking University. All animals received humane care
in compliance Guide for the Institutional Animal Care and Use
Committee (IACUC). CFTR knockout (KO) and heterozygote
(HET) mice were purchased from Jackson Lab(CFTR S489X-)
and bred to generate homozygous mutants (KO), heterozygote
(HET), and wild-type (WT) mice. CFTR KO mice were
genotyped by standard PCR according to the genotyping
protocol. Mice were housed under controlled temperature
(21◦C) on a 12 h light-dark cycle with unrestricted access
to food and water.
FABP-hCFTR-CFTR transgenic mice harbor the FABP-
hCFTR transgene and a targeted knock-out mutation of the
CFTR. This model may be used to assess the effects of the
null mutation and may be useful as a mouse model of severe
phenotype cystic fibrosis.
Glucose Tolerance Test, Insulin
Tolerance Tests, and Determination of
Insulin Levels in vivo
For glucose tolerance tests (GTTs), the mice were starved
overnight and were given 2.5 g/kg body weight of glucose by
IP injection. Blood was then taken from the tail vein before
and 15, 30, 60, and 120 min after injection to determine blood
glucose by using an Accu-Chek blood glucose monitor (Roche).
To determine insulin plasma levels, blood was collected, and the
plasma was obtained, and analysis was performed with an insulin
ELISA (Millipore). For ITT, 5 h fasted mice were given human
insulin (0.75 U/kg, Novolin) by IP injection. The blood glucose
concentration was monitored before and after 15, 30, 60, and
120 min after injection. During GTT and ITT, mice were caged
with blinded identity and random orders.
Immunoblotting
The expression and phosphorylation of each protein were
analyzed by Western blot analysis. The membrane protein was
extracted by using a membrane protein extraction kit (Merck
Millipore). The protein was quantified using the Bradford
reagent (BioRad). Before loading into the 10% SDS-PAGE,
the samples were mixed with a 5x loading buffer and boiled
at 98◦C for 5 min. After gel electrophoresis, the proteins
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were then transferred to a PVDF membrane (0.45 µm, Merck
Millipore) under 250 mA for 90 min. The membranes were
incubated with a blocking buffer (5% non-fat milk in Tris-
buffered saline containing 0.5% Tween-20) for 1 h at room
temperature and then incubated with the indicated primary
antibodies at 4◦C overnight. The membrane was incubated with
horseradish peroxidase-conjugated secondary antibody for 1 h
at room temperature. The target protein bands were visualized
using Amersham Imager 600 (GE healthcare).
Rabbit polyclonal to GLUT4(ab654,1:2,000), Rabbit polyclonal
to PIP5K1A(ab654,1:1,000), and Mouse monoclonal to alpha 1
Sodium Potassium ATPase(ab7671, 5 µg/ml) were purchased
from Abcam (United Kingdom); Mouse Monoclonal Antibody to
β-tubulin(TDY041, 1:1,000), Mouse Monoclonal Antibody to β-
actin(TDY045, 1:1,000), Goat Polyclonal Antibody to Mouse IgG
(H + L), HRP Conjugated(S001, 1:1,000), and Goat Polyclonal
Antibody to Rabbit IgG (H + L), HRP Conjugated(S004, 1:1,000)
were from TDY(Beijing, China).
Dot-Blot Analysis
PI(4,5)P2 were measured by dot-blot analysis. C2C12 myotubes
were treated with CFTR (inh)-172(Chemegen) for 24 h. FDB
muscle fibers isolated from CFTR KO, HET, WT mice. The
whole-cell lysates were then extracted from C2C12 myotubes, and
FDB muscle fibers were blotted onto nitrocellulose membranes
(Bio-Rad Laboratories). These were probed with PI(4,5)P2
antibody (Abcam, # ab11039) at a 1:500 dilution and detected
using a horseradish peroxidase-conjugated secondary antibody
(Beijing TDY Biotech LTD, #E009) and were visualized using
Amersham Imager 600 (GE healthcare). Experiments were
repeated at least three times.
[3H]2-Deoxy-D-Glucose Uptake Assay
Uptake of [3H]2-deoxyglucose (Sigma, 73698-45-0) was
measured in C2C12 myocytes differentiated in 24-well plates.
After differentiation, cells were washed twice with DMEM
(GIBCO #11965) and incubated in the DMEM for 2 h at 37◦C.
Cells were then washed twice in PBS and then incubated in
KRBB (G-clone, RS1800) in the presence or absence of insulin
for 30 min at 37◦C. CFTR (inh)-172 was added 30 min before
insulin. After insulin treatment, uptake of 10 µM [3H]2-
deoxyglucose was measured for 15 min at 37◦C. Reactions were
terminated by rapidly washing the cells twice with cold KRBB.
Cells were then were lysed in 0.1 N NaOH with SDS 0.1%, and
radioactivity was determined by liquid scintillation counting and
normalized according to the total protein content. Non-specific
uptake was determined in the presence of 20 µM cytochalasin B.
The mice’s skeletal muscle was quickly dissected after killing
the mice. Before the experiment, mice have fasted for 12 h. Do
not disturb the mice and keep them in a resting state. The muscles
were incubated in KRBB in the presence or absence of insulin
for 30 min at 37◦C, uptake of 10 µM [3H]2-deoxyglucose was
measured for 15 min at 37◦C, as described above.
Statistical Analysis
All statistical calculations were carried out using Graphpad
Prism 6. Data are expressed as average ± SEM of at least
three independent experiments. The statistical significance was
determined using a t-test when comparing two groups and
ANOVA when comparing multiple groups. A value of P < 0.05
was considered statistically significant.
RESULTS
CFTR Dysfunction Affects Mice’s
Glucose Homeostasis and Body Weight
To investigate the connection between CFTR and glucose
homeostasis, we performed insulin tolerance tests and glucose
tolerance tests in 20-weeks-old male WT, heterozygous(HET),
and CFTR KO mice (Figures 1A,B). During intraperitoneal
insulin tolerance tests, the decrease in blood glucose was less
marked in CFTR−/− mice than that of WT and HET mice
following 10 mg/ml insulin injection (Figure 1A), suggesting
insulin resistance. Moreover, the blood glucose level in CFTR−/−
mice was also much higher than that of WT and HET mice
2 h after insulin injection (Figure 1A). It took CFTR−/−
mice 60 min to reach the blood glucose summit in response
to glucose tolerance tests, while it only took 15 min in WT
and HET mice(Figure 1B). However, the glucose AUC was
similar among WT and KO groups but slightly lower in the
HE group (Figure 1C), indicating that the delay in attaining
peak glucose levels during the OGTT suggests delayed glucose
absorption. Reduced first, second, and amplifying phase secretion
in CF islets have been reported by numerous researchers (Sun
et al., 2017; Kelly et al., 2019); however, it was found that
serum insulin level of CFTR−/− mice showed no significant
difference than WT and HET mice by ELISA (Figure 1D),
indicating that the amount of insulin secretion by CFTR−/−
mice was normal before CFRD. Notably, maintained in a
stable environment with standard chow and water, CFTR−/−
mice’s average body weight was much lower than WT and
HET mice (Figure 1E). We suspected that the lower body
weight of CFTR−/− mice resulted from inadequate glucose
intake, but other possibilities include CFTR-related glucosuria
or increased metabolic rate, requiring further confirmation. In
conclusion, CFTR dysfunction affects mice’s glucose homeostasis
and body weight.
CFTR Is Essential to Insulin-Induced
GLUT4 Cell Membrane Translocation and
Glucose Uptake
When GLUT4 glucose transporters are present in cytoplasmic
vesicles, they are useless for transporting glucose. The binding
of insulin to receptors on such cells leads rapidly to the
fusion of those vesicles with the plasma membrane and the
insertion of the glucose transporters, thereby giving the cell
the ability to take up glucose efficiently. As a result, glucose
uptake depends on insulin-stimulated membrane translocation
of the GLUT4. To investigate the relation between CFTR
and GLUT4, GLUT4 cell membrane expression was measured
by western blot in mice skeletal muscle fibers and C2C12
myotubes. The Flexor Digitorum Brevis (FDB) muscle fibers
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FIGURE 1 | Insulin resistance and Glucose tolerance in CFTR knockout mice. (A) Intraperitoneal insulin tolerance tests were performed in 20-weeks-old male mice
WT, HET, and CFTR KO mice. **P < 0.01; NS, not significant. (B) OGTTs were performed in 20-weeks-old male mice WT, HET, and CFTR KO mice. **P < 0.01; NS,
not significant. (C) Area under the curve (AUC) of changes in blood glucose levels. (D) Following an injection of 250 mg/ml glucose, serum insulin concentration was
measured by ELISA. NS, not significant. (E) Bodyweight was measured in 20-weeks-old male mice WT, HET, and KO mice. Data are mean ± SEM of 7–9 mice per
group. **P < 0.01 vs. WT.
total membrane protein were immediately isolated from WT,
HET, and CFTR KO mice 30 min after insulin injection
stimulation. Evident membrane translocation of GLUT4 was
found in WT and HET mice muscle fibers with insulin
stimulation (Figure 2A). However, there was no membrane
expression of GLUT4 in CFTR−/− mice with or without
insulin stimulation (Figure 2A). Consistent with this, the
insulin-stimulated GLUT4 cell surface translocation was also
blocked by a specific CFTR inhibitor [CFTR (inh)-172] in
differentiated C2C12 myotubes (Figure 2B). To directly show
the translocation of GLUT4, C2C12 myoblasts and myotubes
were transiently transfected with myc–GLUT4–EGFP fusion
plasmids. Myc epitope was inserted in the first exofacial loop
of GLUT4 N terminus and presented outside of the cell
membrane, which could be detected by the antibody without
perforation. C2C12 Cells were then fixed (without perforation)
and labeled with an anti-Myc antibody followed by Texas
Red secondary to track the membrane translocation of GLUT4
(red). We found that GLUT4 was expressed in the cytoplasm
(Figures 2C,D, Control), and insulin could induce translocation
of GLUT4 to cell membranes both in C2C12 myoblasts and
myotubes (Figures 2C,D). However, this process could be
blocked by CFTR (inh)-172 (Figures 2C,D). The effects of
CFTR (inh)-172 on insulin-stimulated glucose uptake activity
were also tested in differentiated C2C12 myotubes and freshly
isolated Flexor Digitorum Brevis (FDB) muscle fibers cells.
We found that CFTR (inh)-172 significantly decreased 2-DG
uptake in insulin-stimulated C2C12 myotubes (Figure 2E) and
freshly isolated Flexor Digitorum Brevis (FDB) muscle fibers
cells (Figure 2F).
Some tissues, such as the liver, do not require insulin for
efficient uptake of glucose; this is because these cells do not
use GLUT4 to import glucose, but rather, GLUT1 and GLUT2
are not insulin-dependent. We wondered if similar results
could be observed in liver cells. HEPG2 cells were transiently
transfected with myc–GLUT4–EGFP fusion plasmids. HEPG2
Cells were then fixed (without perforation) and labeled with
an anti-Myc antibody followed by Texas Red secondary to
track the membrane translocation of GLUT4 (red). It was
found that CFTR (inh)-172 could also block insulin-induced
GLUT4 membrane translocation in HEPG2 (Supplementary
Figure S1A) and Hela cells (Supplementary Figure S1B). To
further confirm CFTR’s role on GLUT4 translocation, as Hela
cells endogenously express CFTR (Billet et al., 2017), we knocked
out CFTR in Hela cells by CRISPR/Case9 (Supplementary
Figure S1C). It was found that insulin could no longer induce
GLUT4 translocation to the cell membrane in CFTR−/− cells
(Supplementary Figure S1D). Taken together, these results
suggested that CFTR was required in insulin-induced membrane
translocation of GLUT4.
PI(4,5)P2 Rescues CFTR Related
Defective GLUT4 Translocation
Several studies indicated that Rab8A and Rab13 could also
contribute to the translocation of GLUT4 (Sano et al., 2007;
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FIGURE 2 | CFTR regulates GLUT4 membrane translocation and glucose homeostasis. (A) The membrane localization of GLUT4 in CFTR KO mice FDB muscle
after injection of 10 mg/ml insulin was measured by Western blot. Images are representative of triplicate experiments with similar results. **P < 0.01 compared with
control (n = 3). (B) The membrane expression of GLUT4 in C2C12 myotubes was measured by Western blot. **P < 0.01 compared with control (n = 3).
(C) myc-GLUT4- GFP was transfected into C2C12 myoblasts by adenoviruses. The cells were stimulated with insulin (100 nM) for 30 min. GLUT4 translocation to
the plasma membrane was detected by confocal microscopy. Glut4-GFP(green), Glut4-myc(red). Scale bar, 10 µm. (D) GLUT4 translocation to the plasma
membrane of differentiated C2C12 myotubes was detected by confocal microscopy. Glut4-GFP(green), Glut4-myc(red). Scale bar, 10 µm. (E) The glucose uptake
assay of C2C12 cells. Data are mean ± SD values for two independent assays performed in triplicate. ***P < 0.001, *P < 0.05. (F) The glucose uptake assay of
Flexor Digitorum Brevis muscle fibers cells. Data are mean ± SD values for two independent assays performed in triplicate. ***P < 0.001, **P < 0.01.
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Randhawa et al., 2008; Sun et al., 2010). Rab8A or Rab13
was co-transfected with myc-GLUT4-EGFP in Hela cells; we
found that Rab8A or Rab13 could not rescue GLUT4 membrane
translocation under CFTR (inh)-172 treatment (Figure 3A),
suggesting Rab8A or Rab13 is not involved in this process.
PI(4,5)P2 mediated insulin-induced actin remodeling is another
crucial component in GLUT4 translocation (Kanzaki and
Pessin, 2001; Kanzaki et al., 2004; Leto and Saltiel, 2012;
Lim et al., 2015). To identify the role of PI(4,5)P2 in
the process of GLUT4 translocation, C2C12 myotubes were
transiently transfected with myc–GLUT4–EGFP fusion plasmids.
Insulin-induced GLUT4 translocation in C2C12 myotubes
was blocked after endogenous PI(4,5)P2 was depleted by
application of both PI3K inhibitor (wortmanin) and PLC agonist
(Figure 3B). The defective GLUT4 membrane translocation
induced by CFTR (inh)-172 could also be rescued by exogenous
PI(4,5)P2 (Figure 3B). As CFTR is a chloride channel, we
suspected whether the chloride channel property of CFTR
was also involved with GLUT4 translocation. By replacing
the chloride with arginine in bath solution, we found that
the translocation of GLUT4 was still blocked by CFTR (inh)-
172 (Supplementary Figure S2A). In conclusion, these results
indicated that CFTR regulated GLUT4 membrane translocation
by PI(4,5)P2.
CFTR Affects PI(4,5)P2 Concentration via
PIP5K1A
To confirm the speculation that inhibition of CFTR might affect
cellular PI(4,5)P2 concentration. PI(4,5)P2 concentration was
detected by dot-blot analysis. C2C12 myotubes were treated
with CFTR (inh)-172 for 24 h, and we found that CFTR (inh)-
172 could significantly down-regulate PI(4,5)P2 concentration
(Figure 4A). We also measured the concentration of PI(4,5)P2
in FDB muscle fibers isolated from CFTR WT, HET, and
KO mice. The concentration of PI(4,5)P2 in CFTR−/− mice
FDB muscle fibers was significantly lower than WT and
HET mice (Figure 4B). PIP5K1A induces the phosphorylation
of phosphatidylinositol 4-phosphate (PtdIns4P) to generation
PI(4,5)P2. Studies indicated that that PI(4,5)P2 generation by
PIP5K1A was associated with GLUT4 vesicle recycling (Kanzaki
et al., 2004) and autophagic lysosome reformation (Rong
et al., 2012). To understand how CFTR regulates PI(4,5)P2
expression, the PIP5K1A expression level was measured. We
found that CFTR (inh)-172 induced a reduction of PIP5K1A
expression in C2C12 myotubes (Figure 4C). The expression of
PIP5K1A was also significantly decreased in CFTR−/− FDB
muscle fibers (Figure 4D). These results suggest that the effect
of CFTR on PI(4,5)P2 concentration is via the regulation of
PIP5K1A expression.
DISCUSSION
In this study, we discovered a previously unrecognized regulation
effect of CFTR to the GLUT4 cellular translocation, which
provides a new perspective on the mechanism of CFRD. It was
found that CFTR−/− mice exhibited normal insulin secretion
but reduced insulin sensitivity and glucose tolerance. Insulin
facilitates the entry of glucose into muscle through GLUT4.
Meanwhile, Insulin-induced GLUT4 translocation to the cell
membrane was also blocked in CFTR−/− mice, suggesting
glucose homeostasis alteration from defective intracellular
GLUT4 transportation. Unexpectedly, PI(4,5)P2 could rescue
the effect of CFTR deficiency. Furthermore, it was found that
CFTR deficiency leads to a significantly decreased expression
of PIP5K1A, which reflected on PI(4,5)P2 concentration.
Taken together, we discovered a new signal pathway of
CFTR/GLUT4, which helps explain the glucose homeostasis
disorder in CF patients.
To explain CFRD, several studies have shown that CFTR
played a vital role in the regulation of insulin secretion
and β cell function (Tofe et al., 2005; Noronha et al.,
2011; Konrad et al., 2013; Edlund et al., 2014; Guo et al.,
2014). Some studies suggested that insulin resistance was not
an essential determinant in CFRD compared with insulin
secretion (Cucinotta et al., 1994; Yung et al., 2002). Other
studies proved that insulin resistance was highly involved in
CFRD, and impaired insulin responses were also reported
in CF patients (Hardin et al., 1997; Hardin et al., 2001;
Fontes et al., 2015). Our data show that insulin secretion
is normal in CFTR−/− mice (Figure 1C); the problem
is insulin sensitivity (Figure 1A) and glucose absorption
(Figure 1B). Consistent with previous studies (Paroni et al.,
2013; Fontes et al., 2015), we also found that the body weight
was lower in CFTR−/− mice than WT and HET controls
(Figure 1D). Gradual pancreatic destruction in cystic fibrosis
causes progressive insulin deficiency. Our results show that
in the early stage of CFRD, insulin secretion is expected,
so insulin deficiency may not be due to the destruction of
pancreatic islets, leading to insufficient insulin secretion, but
because CFTR dysfunction affects the insulin-responsive tissues,
which manifests as insulin deficiency. In summary, we believe
that CFTR affects the pancreas functionality and the insulin-
responsive tissues; both contribute to cystic fibrosis-related
diabetes (CFRD).
How does CFTR knock out affected insulin sensitivity and
glucose tolerance? By binding and activating its cell-surface
receptor, insulin triggers signaling cascades that regulate many
cellular processes, including stimulating the muscle to dispose
of dietary glucose (Richter and Hargreaves, 2013). Insulin
stimulation of glucose uptake into muscle depends on the
mobilization of GLUT4 to the plasma membrane (Lauritzen
et al., 2010; Klip et al., 2014). As Akt2 is an essential kinase
in insulin resistance (Cho et al., 2001; McCurdy and Cartee,
2005), we investigate the phosphorylation of Akt2 in CFTR−/−
mice. Surprisingly, CFTR deficiency showed no connection with
phosphorylation of Akt2 and its downstream protein AS160 (data
not shown). Furthermore, other regulators, such as Rab8A and
Rab13, also showed no significant impact on CFTR deficiency-
induced GLUT4 translocation (Figure 3A). As a result, we
focused on the "railway" of protein trafficking in the cell, and
studies showed that actin remodeling also played an essential
regulatory role in insulin-induced GLUT4 translocation (Kanzaki
and Pessin, 2001; Tong et al., 2001). The role of actin dynamic
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FIGURE 3 | PI(4,5)P2 rescues CFTR related defective GLUT4 translocation. (A) The membrane localization of GLUT4 in Hela cells after overexpression of Rab8 and
Rab13 was detected by confocal microscopy. Glut4 (green), Scale bar, 10 µm. (B) C2C12 myotubes were treated with insulin, CFTR inh172, PIP2 depletion agents,
or PI(4,5)P2. PIP2 depletion agents are consist of PI3K inhibitor (1 µM wortmanin) and PLC agonist (50 µM m-3M3FBS). GLUT4 translocation to the plasma
membrane was detected by confocal microscopy. Glut4-GFP (green), Glut4-myc (red). Scale bar, 10 µm.
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FIGURE 4 | CFTR regulates PIP5KA expression and PI(4,5)P2 concentration. (A) C2C12 myotubes were treated with CFTR inh172, and the concentration of
PI(4,5)P2 was measured by dot blot. **P < 0.01 compared with control (n = 3). (B) The concentration of PI(4,5)P2 in mice FDB muscle was measured by dot blot.
**P < 0.01 compared with control (n = 3). (C) C2C12 myotubes were treated with CFTR inh172, and the protein level of PIP5KA was measured by western blot.
**P < 0.01 compared with control (n = 3). (D) The protein level of PIP5KA in mice FDB muscle was measured by western blot. **P < 0.01 compared with control
(n = 3).
regulated by PI(4,5)P2 in GLUT4 translocation has been proved
by recent studies (Kanzaki and Pessin, 2001; Kanzaki et al.,
2004; Leto and Saltiel, 2012; Lim et al., 2015). Our data show
that the depletion of PI(4,5)P2 blocks GLUT4 trafficking to the
cell membrane, and exogenous PI(4,5)P2 can rescue the effect
of CFTR deficiency. Thus, we conclude that CFTR in GLUT4
translocation regulation is mediated by PI(4,5)P2. In addition to
insulin-stimulation, the translocation of GLUT4 to the plasma
membrane is also affected by skeletal muscle contraction.
Whether CFTR has a role in skeletal muscle contraction needs
further clarification.
As CFTR is an ion channel, which makes no sense in catalyzing
PI(4,5)P2 generation. We proved that the chloride channel
property of CFTR was not involved with GLUT4 translocation;
only the protein itself is involved in translocation. Therefore,
we speculated that CFTR allosteric affects some kinase proteins
in the regulation of PI(4,5)P2 generation. The differential gene
expression induced by CFTR deficiency has been reported by
several studies (Ichikawa et al., 2000; Ogilvie et al., 2011; Chen
et al., 2012). We suspected that inhibition or knockdown of CFTR
might lead to decreased PIP5K1A expression, which regulates
PI(4,5)P2 generation. We found that the expression of PIP5K1A
in CFTR−/− mice and CFTR (inh)-172 treated C2C12 was
significantly reduced, causing lower PI(4,5)P2 concentration. In
conclusion, PIP5K1A is one of the regulators between CFTR and
PI(4,5)P2, but further investigation is needed to assess how CFTR
deficiency regulates PIP5K1A expression.
In summary, our results suggest a new mechanism of glucose
homeostasis disorder in CF patients. These findings identify
the role of GLUT4 translocation in CFTR related glucose
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homeostasis disorder in CF patients, which provides a new
potential treatment strategy.
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